Please note: The Research + Innovation office will be closed for the holidays from noon on December 24 through January 2nd, inclusive. 鉂勶笍 Veuillez noter que le bureau de la Recherche et de l'Innovation sera ferm茅 pour les vacances du 24听d茅cembre 脿 midi jusqu鈥檃u 2听janvier inclus.
subscribe 
平特五不中 to partner with CCRM in commercializing regenerative medicine
平特五不中 announced today it has concluded an agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to provide 平特五不中-based startup companies with the benefit of CCRM鈥檚 market-leading business intelligence and experience.
Email address:
Published: 10 Mar 2021
$110M for Nine Innovative 平特五不中 Research Projects
Read the story in the 平特五不中 Reporter
Read the 平特五不中听news release
Email address:
Published: 9 Mar 2021
Marc Rousseau joins 平特五不中 as Director, Research Software
Research and Innovation and IT Services are pleased to welcome Marc Rousseau to the role of Director, Research Software / Directeur du Logiciel de Recherche. In this new role, Rousseau provides support and advice to the 平特五不中 research community on software, from grant applications to the implementation of research activities.
Published: 25 Feb 2021
Diamond Therapeutics Signs Agreement with 平特五不中 for Research on Low-Dose LSD
TORONTO,听Feb. 4, 2021听/CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement with听平特五不中听for the exclusive use of Dr.听Gabriella Gobbi's听groundbreaking studies with lysergic acid diethylamide (LSD), its mechanism of action on the brain, and its potential for use at low doses in the treatment of mental health disorders.听
Published: 4 Feb 2021
Four 平特五不中 projects receive SSHRC Partnership Engage Grants
SSHRC invests over $80k in new 平特五不中 research projects through the Partnership Engage Grants competition, two of which are directly related to COVID-19 research.
Published: 28 Jan 2021
Major European grant backs 平特五不中 research on rare condition
The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel-Giedion Syndrome (SGS).
Published: 27 Jan 2021
平特五不中 team wins grant to study 鈥榯rained immunity鈥� with Japanese researchers
Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening 平特五不中鈥檚 relationship with Japan鈥檚 RIKEN institute.
By Junji Nishihata
Email address:
Published: 21 Dec 2020
Reminder: Canada Research Continuity Emergency Fund (CRCEF)
This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.
Published: 10 Nov 2020
Kristina 脰hrvall promoted to Assistant Vice-Principal, Research Development
Martha Crago, Vice-Principal, Research and Innovation, announced today that Kristina 脰hrvall has been promoted to Assistant Vice-Principal, Research Development, for a five-year term.
Published: 9 Nov 2020
Research and Innovation on a summer schedule, starting June 26
Please note that Research and Innovation (R+I), including all of its associated units, will soon change to a summer schedule as per 平特五不中鈥檚 policy on Summer Fridays.
In practice, this means R+I will function with only minimal staff on Fridays throughout the summer, from June 26 until August 21. R+I will resume regular weekly office hours on Friday, August 28.
Published: 15 Jun 2020
Updates on Research Support during the Pandemic
Sent on behalf of Martha Crago, Vice-Principal (Research and Innovation)
听
Dear Colleagues,
I have been thinking of you often, as research is slowly 鈥巗tarting up again at 平特五不中.
Published: 15 Jun 2020
Call to 平特五不中 Researchers: Complete survey on COVID-19 Diagnostics R&D
The availability of reliable, rapid diagnostics is key to reopening our economies. Canada has an opportunity to take a leadership role in accelerating the development of these tests through a coordinated Canadian response. The goal is to support researchers to build networks and find collaborators/industry partners to advance their ideas to clinical trial and mass production. To that end, Dr.
Email address:
Published: 29 May 2020
Help fight COVID-19 by joining the CanCOVID initiative
平特五不中 faculty with relevant expertise are encouraged to join the CanCOVID鈥痠nitiative, an expert community of Canadian COVID-19 researchers, clinical collaborators, and healthcare stakeholders.
Published: 17 Apr 2020
平特五不中 spinoff Laurent Pharmaceuticals to begin clinical trial on COVID-19 treatment
Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus
Published: 9 Apr 2020
Message to the 平特五不中 research community about CFI projects
On March 20, 2020, the Government of Quebec announced an immediate shutdown of constructions sites due to the COVID-19 pandemic. On April 7, it was announced that the date to resume construction activities is听May 4, 2020. This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.听
Published: 6 Apr 2020